IQVIA Biotech JAPAC
Welcome to IQVIA Biotech in Japan and Asia Pacific (JAPAC), the extension of IQVIA Biotech global, aimed at providing a custom-built delivery solution for emerging biopharma and biotech customers.
Presence in JAPAC
With our regional headquarters in Singapore and offices in 15 countries, IQVIA Biotech provides technology-enabled services and solutions to accelerate clinical and commercial success for local and multinational emerging biopharma clients operating in Japan and Asia Pacific.
IQVIA's Experience
1,460+
studies run by IQVIA over the last five years across all therapeutic areas throughout JAPACIQVIA's Coverage
17,700+
sites initiated by IQVIA over the last five years throughout JAPACIQVIA's Coverage
162K+
IQVIA patients enrolled throughout JAPAC in all therapeutic areas in the last five yearsFlexible solutions designed for Biotech Companies
Leadership Team
Biotech companies from the region have emerged as critical drivers of innovation, and when they succeed, we all succeed. I am inspired by the passion and dedication of the people behind these organizations that led us to build this business unit to mirror our biotech customers – a flat and nimble organization with streamlined process, and the right therapeutic expertise to help our customers succeed and advance human health with newfound confidence.
On-Demand webinar
Global Strategies for Accelerating Time to Market for Emerging Biopharmas
Register now 